Bill Commons

NY A 6923

in committee

Requires health insurance plans to provide coverage for continuous blood glucose monitors for all children

New York · 2025-2026 Regular Session · lower

Quick answers

Did NY A 6923 pass?

Not yet. NY A 6923 is in committee as of 2026-02-04 and has not come to a final vote. Latest recorded action (2026-02-04): PRINT NUMBER 6923A

What is NY A 6923 about?

Requires health insurance plans to provide coverage for continuous blood glucose monitors for all children; requires coverage for glucose monitoring devices for all sugar disorders.

Who sponsors NY A 6923?

David Weprin is the primary sponsor of NY A 6923, joined by 4 cosponsors.

Description

Requires health insurance plans to provide coverage for continuous blood glucose monitors for all children; requires coverage for glucose monitoring devices for all sugar disorders.

Introduced
Latest action
2026-02-04 — PRINT NUMBER 6923A
Bill type
bill
Last updated

Sponsors

  • David Weprinprimary
  • Stacey Pheffer Amatocosponsor
  • MaryJane Shimskycosponsor
  • Judy Griffincosponsor
  • Rebecca Kassaycosponsor

Committees

Not provided by source.

Action timeline

  1. 2025-03-18

    REFERRED TO INSURANCE

    referral-committee

  2. 2026-01-07

    REFERRED TO INSURANCE

    referral-committee

  3. 2026-02-04

    AMEND AND RECOMMIT TO INSURANCE

    amendment-passage,referral-committee

  4. 2026-02-04

    PRINT NUMBER 6923A

    amendment-passage

Versions

Documents

Votes

Not provided by source.

Related bills

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z

Inspect retained evidence for changes recorded after evidence tracking began:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=A 6923. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.